SV Health Investors

Boston, Massachusetts
cb
Firm Location:Boston, Massachusetts • Cambridge, Massachusetts • San Mateo, California • London • Stockholm, Sweden • United Kingdom
Investor Firms That Co-Invest with SV Health Investors
AbingworthAisling CapitalRA CapitalMorgenthaler VenturesCambridge Innovation Capital7wire VenturesSandbox IndustriesNew Leaf Venture PartnersNovartis Venture FundDolby Family VenturesAtlas VentureLightstone VenturesThird Rock VenturesRiverVestAscension VenturesBain Capital Life SciencesSanofi VenturesMP Healthcare Venture ManagementMRL Ventures FundOmega FundsBrandon Capital PartnersBorealis VenturesM Ventures (Merck)Soffinova PartnersSection 32U.S. Venture Partners (USVP)Polaris PartnersSOSVOrbiMedGV (Google Ventures)McKesson VenturesB Capital Group
SV Health Investors Team
Photo of Houman Ashrafian, Managing Partner at SV Health Investors
Houman Ashrafian
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in London (Other Lists)
to see your intro paths to Houman
Photo of Alex Badamchi-Zadeh, Senior Associate at SV Health Investors
Alex Badamchi-Zadeh
SV Health Investors·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)
to see your intro paths to Alex
Photo of Josh Baker, Analyst at SV Health Investors
Josh Baker
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to Josh
Photo of Michael Balmuth, Managing Partner at SV Health Investors
Michael Balmuth
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Michael
Photo of Laurence Barker, Partner at SV Health Investors
Laurence Barker
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in London
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in London (Other Lists)
to see your intro paths to Laurence
Photo of Jonathan Behr, Partner at SV Health Investors
Jonathan Behr
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
to see your intro paths to Jonathan
Photo of Kate Bingham, Managing Partner at SV Health Investors
Kate Bingham
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $30K - $3.0M
Investors in London
to see your intro paths to Kate
Photo of Rebecca Canter, Associate at SV Health Investors
Rebecca Canter
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
to see your intro paths to Rebecca
Photo of Charles Dunn, Associate at SV Health Investors
Charles Dunn
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom, Investors in London
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in London (Other Lists)
to see your intro paths to Charles
Photo of Tom Flynn, Managing Partner at SV Health Investors
Tom Flynn
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to Tom
Photo of William Gerard, Analyst at SV Health Investors
William Gerard
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to William
EH
Eugene Hill
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston / New England, Investors in Boston (MA)
to see your intro paths to Eugene
Photo of Christian Jung, Partner at SV Health Investors
Christian Jung
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom, Investors in London
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in London (Other Lists)
to see your intro paths to Christian
Photo of Jack Kenney, Associate at SV Health Investors
Jack Kenney
Sweet spot: $1.5M
Range: $30K - $3.0M
Investors in Europe, Investors in Israel, Investors in United Kingdom, Investors in United States
to see your intro paths to Jack
Photo of Dirk Landgraf, Principal at SV Health Investors
Dirk Landgraf
Sweet spot: $5.0M
Range: $1M - $10.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Diverse Investors (Other Lists), Investors in Therapeutics (Series B), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in Therapeutics (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Dirk
Photo of Paul LaViolette, Managing Partner at SV Health Investors
Paul LaViolette
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Paul
Photo of Megan MacDonagh, Senior Associate at SV Health Investors
Megan MacDonagh
SV Health Investors·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to Megan
Photo of Greg Madden, Managing Partner at SV Health Investors
Greg Madden
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diverse Investors (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Greg
Photo of Niyoshi Patel, Associate at SV Health Investors
Niyoshi Patel
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to Niyoshi
Photo of Marek Poszepczynski, Investor at SV Health Investors
Marek Poszepczynski
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Stockholm (Sweden)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
to see your intro paths to Marek
Photo of Mike Ross, Managing Partner at SV Health Investors
Mike Ross
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States, Investors in SF Bay Area (CA), Investors in San Francisco (CA), Investors in San Mateo (CA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B)
to see your intro paths to Mike
Photo of Alexander Sinclair-Wilson, Analyst at SV Health Investors
Alexander Sinclair-Wilson
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in London (Other Lists)
to see your intro paths to Alexander